 |
Adenosine |
|---|---|
| Trade Name | |
| Orphan Indication | For use in conjunction with BCNU in the treatment of brain tumors |
| USA Market Approval | USA |
| USA Designation Date | 1989-08-01 00:00:00 |
| Sponsor | Medco Research, Inc.;8455 Beverly Boulevard, Suite 308;Los Angeles, California, 90048 |
